Ask AI
WU KONG28
WU-KONG28: Phase III Trial of First-line Sunvozertinib vs Platinum-Based Chemotherapy in Advanced NSCLC With EGFR Exon 20 Insertion Mutations

Released: June 24, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: June 24, 2026